Diagnostic delay is not, in itself, a basis for liability. Legal inquiry begins when a delay can be shown to have altered the clinical course in a way that produced permanent neurological injury. Courts evaluating these cases focus on whether a condition was identifiable within a clinically meaningful window, whether appropriate diagnostic steps were taken […]
Causation analysis in brain injury cases becomes materially more complex where a metabolic disorder is present. Metabolic conditions, whether genetic or acquired, can independently produce neurological impairment, alter the brain’s response to injury, or affect recovery trajectories. Courts evaluating such cases do not assume a single cause. The inquiry instead requires a structured assessment of […]
Newborn screening programs are designed to identify serious but treatable conditions before clinical deterioration occurs. When results from the screening program are delayed, misreported, or not acted upon, the legal inquiry centers on whether the failure disrupted a time-sensitive opportunity to prevent neurological injury. Courts evaluating these cases focus on the sequence of events link […]
Claims involving mild traumatic brain injury (mTBI) form a point of contention in litigation, particularly when the injury is accompanied by significant functional impairment. The diagnostic designation of “mild” reflects initial clinical criteria—such as brief alteration of consciousness or limited observable findings—not the ultimate severity of outcome. Courts evaluating cases involving mild TBIs but severe […]
In cases involving neurological harm, a central issue is the distinction between hypoxic brain injury and traumatic brain injury, particularly when multiple potential mechanisms are implicated. Courts do not resolve this distinction based on diagnostic labels alone. The inquiry requires a disciplined evaluation of whether the evidentiary record supports one mechanism of injury over another, […]